Patient
SITE012-0164
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE012 (BRA) (Dr. Kowalski)
consented 2026-03-17
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 3
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2023-03-13 (study day 171); relationship: RELATED
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-11-25 (study day 63); relationship: not assessed
Grade 3 Colitis — outcome: RECOVERED/RESOLVED; onset 2022-10-17 (study day 24); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.